OR022 Tolerance of needleless subcutaneous immunotherapy in children
Pain, local reactions and the fear of anaphylaxis due to inadvertent intravenous administration limit the use of subcutaneous immunotherapy (SCIT) in children. We evaluate its tolerability when delivered by a needleless device.
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: A. Fiocchi, G. Traina, A. Martelli, V. Fierro, R. Valluzzi, M. Mennini Source Type: research
More News: Allergy | Allergy & Immunology | Anaphylactic Shock | Asthma | Children | Immunotherapy | Men | Pain